Evidence map›Paper›PMID 39547701›Full record

ArticleGlobal health, science and practice2024

Hybrid Mentorship of Medical Laboratories to Achieve ISO 15189:2012 Accreditation in Malawi: The University of Maryland Malawi Experience.

Hannaniah Moyo, Sophia Osawe, Charles Nyangulu, Philemon Ndhlovu, Visopo Harawa, Oscar Divala, Malango Msukwa, Talishiea Croxton, Natalia Blanco, Dyson Mwandama and 13 more

Abstract read
In one paragraph

Article in Global health, science and practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Hannaniah MoyoCenter for International Health, Education, and Biosecurity, Lilongwe, Malawi.
Sophia OsaweInstitute of Human Virology Nigeria, Abuja, Nigeria. sosawe@ihvnigeria.org.
Charles NyanguluCenter for International Health, Education, and Biosecurity, Lilongwe, Malawi.
Philemon NdhlovuCenter for International Health, Education, and Biosecurity, Lilongwe, Malawi.
Visopo HarawaCenter for International Health, Education, and Biosecurity, Lilongwe, Malawi.
Oscar DivalaCenter for International Health, Education, and Biosecurity, Lilongwe, Malawi.
Malango MsukwaCenter for International Health, Education, and Biosecurity, Lilongwe, Malawi.
Talishiea CroxtonCenter for International Health, Education, and Biosecurity, University of Maryland School Medicine, Baltimore, MD, USA.
Natalia BlancoCenter for International Health, Education, and Biosecurity, University of Maryland School Medicine, Baltimore, MD, USA.
Dyson MwandamaUniversity Research Co. Lilongwe, Malawi.
Memory MkandawireUniversity Research Co. Lilongwe, Malawi.
Elizabeth KampiraDivision of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Lilongwe, Malawi.
Muluken KabaDivision of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Lilongwe, Malawi.
Alice MaidaDivision of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Lilongwe, Malawi.
Andrew F AuldDivision of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Lilongwe, Malawi.
Lindsay KimDivision of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Lilongwe, Malawi.
Reuben MwendaDivision of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Lilongwe, Malawi.
Howard KressDivision of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Lilongwe, Malawi.
James KanduluDiagnostic Department, Ministry of Health, Lilongwe, Malawi.
Thresa SumaniDiagnostic Department, Ministry of Health, Lilongwe, Malawi.
Joseph BitilinyuDiagnostic Department, Ministry of Health, Lilongwe, Malawi.
Thokozani KaluaCenter for International Health, Education, and Biosecurity, Lilongwe, Malawi.
Alash'le AbimikuInstitute of Human Virology Nigeria, Abuja, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAs part of a laboratory strengthening program in Malawi to achieve and maintain International Organization for Standardization (ISO) 15189 accreditation, we intended to mentor selected HIV molecular laboratories to achieve this accreditation. Due to the COVID-19 pandemic, mentorship pivoted to a hybrid model using an Internet-based approach and on-site mentorships. We describe the implementation of this strategy, successes, and challenges.

methodsWe conducted weekly, 1-hour virtual mentorship sessions for the 5 initial laboratories (cohort 1) selected based on their Stepwise Laboratory Quality Improvement Process Towards Accreditation (SLIPTA) performance score of 3 or more stars. Laboratories presented updates and supporting documents electronically, and trainings were conducted virtually. In September 2020, when travel restrictions were relaxed, we initiated hybrid mentorships and audits for cohort 1 laboratories. The same hybrid approach was used to mentor 4 additional laboratories in cohort 2. We performed descriptive analysis, and the Wilcoxon signed-rank test was used to compare the training pre-and post-test scores.

resultsBetween March 2020 and May 2023, the team completed a total of 54 virtual mentorship sessions and 20 on-site visits across 9 laboratories. Overall, the team conducted 8 training sessions for 35 laboratory quality officers. Median score improvement (pre-test vs. post-test scores) was observed across individual trainings and across cohorts (

conclusionsWe demonstrated that using a hybrid mentorship model for accreditation was a successful strategy during the COVID-19 pandemic. For the first time in Malawi, this strategy resulted in accrediting 9 of the 10 HIV molecular laboratories in 3 years at a reduced cost. Continuous mentorship is key in the maintenance of accreditation.

Indexed as

AccreditationLaboratoriesMentorsQuality ImprovementCOVID-19HumansMalawiSARS-CoV-2

Identifiers

PMID39547701
PMCPMC11666087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.